Immunome (IMNM) Appoints Phil Roberts as CTO
Get Alerts IMNM Hot Sheet
Join SI Premium – FREE
Immunome, Inc. (Nasdaq: IMNM) today announced the appointment of Phil Roberts as Chief Technical Officer. Mr. Roberts has over three decades of experience in product development, global manufacturing, and commercialization of novel pharmaceutical products.
“Immunome is delighted to add Phil to our management team as we advance our portfolio of immunotherapies, radioligand therapies, and ADCs towards clinical development,” stated Clay Siegall, PhD, President and Chief Executive Officer of Immunome. “With an ambitious pipeline that spans multiple modalities, Phil’s technical leadership will be fundamental in building our organization and to the efficient development of our product candidates.”
“I am excited to join Immunome at this critical stage in the company’s growth, and I look forward to continued expansion of the company’s capabilities,” said Mr. Roberts. “Working with Clay and the entire Immunome team to advance potential best-in-class or first-in-class oncology therapies is a unique opportunity, and I believe we will deliver real results for cancer patients.”
Before joining Immunome, Mr. Roberts was most recently a consulting executive providing strategic and advisory support to emerging biopharmaceutical and research service companies. Prior to that, Mr. Roberts served as SVP, Technical Operations at Mirati Therapeutics, where he was responsible for pharmaceutical product development, manufacturing, and supply chain operations. While at Mirati, Phil built the Tech Ops organization and led the CMC development, accelerated approval and commercialization of Mirati’s first product, Krazati® (a targeted KRAS G12C inhibitor). He has held technical and operations management positions at Avanir, Orexigen, Exelixis, Nektar, Pfizer, Roche and Eli Lilly and has successfully developed and commercialized five novel pharmaceutical products.
Mr. Roberts received his M.S. in Chemical Engineering from Louisiana State University and a B.S. in Chemical Engineering from Rensselaer Polytechnic Institute.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- J.M. Smucker names Jeff Varcoe as SVP of Science and Technical
- CBAK Energy expands Nanjing battery cell capacity toward 18 GWh
- SuperCom wins third Texas electronic monitoring contract
Create E-mail Alert Related Categories
Corporate News, Management ChangesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share